Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Most NMIBC Recurrences Seen in BCG-Exposed Patients
2.
Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria
3.
Modified personalized cancer vaccine generates powerful immune response
4.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
5.
FDA approves Blenrep for relapsed or refractory multiple myeloma
1.
Contemporary Advances in Hematology in the Digital Era
2.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
3.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part VIII
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
4.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Navigating the Complexities of Ph Negative ALL - Part X
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation